Related Experiment Videos
Polyarteritis in children
Insights
Pediatric polyarteritis, a severe vasculitis, showed improved outcomes with combined prednisone and cyclophosphamide treatment. This therapy led to long-term remission in young girls, suggesting enhanced prognosis for childhood polyarteritis.
Area of Science:
- Pediatric Rheumatology
- Vasculitis Research
- Immunosuppressive Therapy
Background:
- Polyarteritis is a rare, severe systemic vasculitis affecting medium-sized arteries.
- Diagnosis in pediatric patients often involves invasive biopsies (kidney, skin).
- Limited data exists on long-term outcomes for childhood polyarteritis.
Observation:
- Three young girls (9-10 years old) diagnosed with polyarteritis.
- Severe disease manifestations included hypertension, seizures, renal failure, and pulmonary infiltrates.
- Treatment involved a combination of prednisone and cyclophosphamide for up to 12 months.
Findings:
- All three patients achieved remission with minimal residual symptoms.
- Long-term follow-up (2-3 years post-therapy) showed sustained recovery.
- Combined corticosteroid and immunosuppressive therapy significantly improved prognosis.
Implications:
- Early and aggressive treatment with combined immunosuppressants is crucial for pediatric polyarteritis.
- This therapeutic approach offers a favorable long-term outlook for affected children.
- Further research into optimal treatment protocols for childhood vasculitis is warranted.
Abstract:
Polyarteritis was diagnosed in three girls, 9 to 10 years old, by kidney and skin biopsies. They were treated with a combination of prednisone (1.5 to 2 mg/kg) and cyclophosphamide (2 mg/kg) for up to 12 months. The illness was severe in all three, complicated by hypertension, seizures, pulmonary infiltrates, renal failure, or hallucinations. All three patients are alive and well with no or minimal residual symptoms two to three years after therapy was discontinued. The treatment with corticosteroids or with a combination of steroids and immunosuppressive drugs seems to improve the prognosis of polyarteritis considerably.